Found: 14
Select item for more details and to access through your institution.
Feasibility of liver transient elastography with FibroScan<sup>®</sup> using a new probe for obese patients.
- Published in:
- Liver International, 2010, v. 30, n. 7, p. 1043, doi. 10.1111/j.1478-3231.2010.02258.x
- By:
- Publication type:
- Article
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211029825
- By:
- Publication type:
- Article
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211029825
- By:
- Publication type:
- Article
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211029825
- By:
- Publication type:
- Article
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920975356
- By:
- Publication type:
- Article
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920975356
- By:
- Publication type:
- Article
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29‐month follow‐up from a randomized, open‐label, phase III trial.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 9, p. 1, doi. 10.1002/cam4.7235
- By:
- Publication type:
- Article
Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1211, doi. 10.3390/biomedicines10051211
- By:
- Publication type:
- Article
Delayed anastomotic leakage following bevacizumab administration in colorectal cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
- Published in:
- Oncology, 2016, v. 90, n. 2, p. 88, doi. 10.1159/000442947
- By:
- Publication type:
- Article
FOLFIRINOX De‐Escalation in Advanced Pancreatic Cancer: A Multicenter Real‐Life Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1701, doi. 10.1634/theoncologist.2020-0577
- By:
- Publication type:
- Article